The observed upregulation of SUCNR1 in human islets during obesity and diabetes, coupled with evidence from our β cell SUCNR1 knockout model, points to a compensatory mechanism aimed at counteracting metabolic challenges. This evidence concerns the gene SUCNR1 and diabetes mellitus.